Bill Sponsor
Senate Bill 4574
116th Congress(2019-2020)
Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act
Introduced
Introduced
Introduced in Senate on Sep 15, 2020
Overview
Text
Sponsor
Introduced
Sep 15, 2020
Latest Action
Sep 15, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4574
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Indiana
Republican
Mississippi
Republican
North Dakota
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a demonstration program for Medicare beneficiaries with end-stage renal disease (ESRD).

Under the program, renal dialysis facilities, kidney disease specialists, physician practices, and other health care practitioners may form an organization that partners with certain health care entities to provide integrated care to beneficiaries with ESRD. Such care must include all covered Medicare benefits as well as transition services for transplantations, palliative care, and hospice. Each organization must have a minimum number or percentage of participating beneficiaries (350 or 60% of beneficiaries served at the organization's facilities) and must also comply with certain fiscal, governance, and quality of care requirements.

Additionally, the Government Accountability Office must study certain data that is reported to the CMS regarding pediatric dialysis care, as well as the effects of race-based corrections to a specified kidney function test on referrals of ESRD patients for transplant evaluations.

Text (1)
September 15, 2020
Actions (2)
09/15/2020
Read twice and referred to the Committee on Finance.
09/15/2020
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:44:46 PM